Lopez-Beltran A - Search Results

1

Emerging immunotherapeutic strategies targeting telomerases in genitourinary tumors.

Carrozza F, Santoni M, Piva F, Cheng L, Lopez-Beltran A, Scarpelli M, Montironi R, Battelli N, Tamberi S. Carrozza F, et al. Crit Rev Oncol Hematol. 2018 Nov;131:1-6. doi: 10.1016/j.critrevonc.2018.07.008. Epub 2018 Aug 1. Crit Rev Oncol Hematol. 2018. PMID: 30293699 Free article. Review.

2

Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation.

Lopez-Beltran A, Cheng L, Andersson L, Brausi M, de Matteis A, Montironi R, Sesterhenn I, van det Kwast KT, Mazerolles C. Lopez-Beltran A, et al. Virchows Arch. 2002 Jan;440(1):3-11. doi: 10.1007/s00428-001-0577-6. Virchows Arch. 2002. PMID: 11942574 Review.

3

Evaluation of prognostic factors in radical prostatectomy specimens with cancer.

Mazzucchelli R, Santinelli A, Lopez-Beltran A, Scarpelli M, Montironi R. Mazzucchelli R, et al. Urol Int. 2002;68(4):209-15. doi: 10.1159/000058437. Urol Int. 2002. PMID: 12053019 Review.

4

Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance.

Lopez-Beltran A, Cheng L. Lopez-Beltran A, et al. Pathology. 2003 Dec;35(6):484-91. doi: 10.1080/00313020310001619127. Pathology. 2003. PMID: 14660098 Review.

5

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis.

Lopez-Beltran A, Bassi P, Pavone-Macaluso M, Montironi R. Lopez-Beltran A, et al. Eur Urol. 2004 Mar;45(3):257-66. doi: 10.1016/j.eururo.2003.09.018. Eur Urol. 2004. PMID: 15036668 Review.

6

Carcinoma of the prostate: inherited susceptibility, somatic gene defects and androgen receptors.

Montironi R, Scarpelli M, López Beltran A. Montironi R, et al. Virchows Arch. 2004 Jun;444(6):503-8. doi: 10.1007/s00428-004-0996-2. Epub 2004 Mar 26. Virchows Arch. 2004. PMID: 15045584 Review.

7

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. A joint proposal of the European Society of Uropathology and the Uropathology Working Group.

Lopez-Beltran A, Bassi PF, Pavone-Macaluso M, Montironi R; European Society of Uropathology; Uropathology Working Group. Lopez-Beltran A, et al. Virchows Arch. 2004 Aug;445(2):103-10. doi: 10.1007/s00428-004-1039-8. Epub 2004 Jun 8. Virchows Arch. 2004. PMID: 15185074 Review.

8

Non-invasive urothelial neoplasms: according to the most recent WHO classification.

Lopez-Beltran A, Montironi R. Lopez-Beltran A, et al. Eur Urol. 2004 Aug;46(2):170-6. doi: 10.1016/j.eururo.2004.03.017. Eur Urol. 2004. PMID: 15245809 Review.

9

Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.

Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Requena MJ, Montironi R. Lopez-Beltran A, et al. Am J Clin Pathol. 2004 Sep;122(3):444-52. doi: 10.1309/LTFU-3UUM-BY09-5HUM. Am J Clin Pathol. 2004. PMID: 15362377

10

c-kit Expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications.

Pan CX, Yang XJ, Lopez-Beltran A, MacLennan GT, Eble JN, Koch MO, Jones TD, Lin H, Nigro K, Papavero V, Tretiakova M, Cheng L. Pan CX, et al. Mod Pathol. 2005 Mar;18(3):320-3. doi: 10.1038/modpathol.3800318. Mod Pathol. 2005. PMID: 15502806 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters